Ligand Enters Into OmniAb® Platform License Agreement with Emergent BioSolutions

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/17/2026

1. JBHT
2. SPY
3. ASML
4. ATAI
5. NVDA
6. JNJ
7. NFLX
8. TSM
9. ASML:NA
10. UNH

Go back to Ligand Enters Into OmniAb® Platform License Agreement with Emergent BioSolutions
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 7.69 -0.2 (2.53%)
Previous Close $7.89    52 Week High $44.38 
Open $7.85    52 Week Low $24.47 
Day High $7.92    P/E 384.50 
Day Low $7.63    EPS $0.02 
Volume 846,912       

LIGAND PHARMA (NASDAQ: LGND) Delayed: 296.45 +0.19 (0.06%)
Previous Close $296.26    52 Week High $139.79 
Open $295.11    52 Week Low $82.07 
Day High $303.58    P/E 689.42 
Day Low $293.67    EPS $0.43 
Volume 241,733